Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics.
Entero Healthcare Solutions Limited (ENTERO) is listed on the NSE in the Healthcare sector, Medical Distribution industry. The ENTERO share price is ₹2,037.10 (+6.84% today), with a market capitalisation of ₹89B and a price-to-earnings (P/E) ratio of 67.9. MarketRipple tracks the ENTERO investment thesis, the ripple-chain impact of market events on Entero Healthcare Solutions Limited, and the Healthcare sector outlook.
Open
₹2,049.00
High
₹2,079.50
Low
₹1,965.60
Prev. Close
₹1,906.70
52W High
₹1,936.60
52W Low
₹944.00
Day range
₹1,965.60–₹2,079.50
52-week range
₹944.00–₹1,936.60
Volume
421K
P/E
67.9
ROE
6.8%
D/E
0.40
Margin
1.8%
Entero Healthcare Solutions Limited (NSE: ENTERO) is currently trading at ₹2,037.10 (+6.84%).
Entero Healthcare Solutions Limited's market capitalization is ₹89B.
Entero Healthcare Solutions Limited's price-to-earnings (P/E) ratio is 67.9.
Entero Healthcare Solutions Limited operates in the Healthcare sector (Medical Distribution).
Analyst consensus on Entero Healthcare Solutions Limited currently reads strongly positive, based on 5 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.